Treatment with LUM/IVA, demonstrated a statistically significant improvement in lung function, as measured by LCI2·5 and percent predicted FEVI (ppFEV1), versus placebo in children with CF homozygous for F508del-CFTR [15]. Here, CFTR is linked to cystic fibrosis.